VANCOUVER, BC / ACCESSWIRE / July 28, 2020 / Experion Holdings Ltd. (the 'Company' or 'Experion') (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the appointment of Mr. Sean MacNeil as Chairman of the Board.

Mr. MacNeil commented, 'I would like to thank our shareholders and the board for giving me this opportunity to lead Experion.

In 2013 Bob Howard and I proudly founded Experion and since that time the cannabis industry has seen incredible changes. And Experion has been there through it all. There have been many obstacles for everyone in our sector over the past few years, and for each of us that managed to overcome them and survive, the foundation for success is built.

I won't sugar coat the fact that Experion has had its share of those challenges. Like the gold rushes of the past, the green rush attracted con men and self-anointed experts. But they are leaving, realizing that now is the time to actually perform, the time to provide what consumers have always expected, the time when smoke and mirrors won't get the job done.

The next phase will see which of the old guard in this new industry will be around in five years and the challenges will be new and many. Experion has a dedicated team of young leaders and the Canadian favorite Citizen Stash brand of products to meet those challenges head on. Experion has a great future.

The cannabis industry is something that I am passionate about, that I understand and have great respect for. Experion will move forward with vigour and I will put my full effort into making it one of Canada's most respected cannabis companies.'

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol 'EXP' on the OTCQB Venture under the symbol 'EXPFF' and on the Frankfurt Stock Exchange under the symbol 'MB31'

For further information, please visit the Company's website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.